immunoSCAPE PTE. LTD.
- Co-Founder and CEO：
- Ng Choon Peng
Enabling immunotherapy through high-dimensional immune profiling
immunoSCAPE is a market-leading biotech company offering state-of-the-art immune profiling service and analytical tools. We enable top pharmaceutical customers around the world to be faster to market by deriving immunological insights that underpin the development of immunotherapies for indications ranging from cancer to infectious and autoimmune diseases.
immunoSCAPE was founded in December 2016 with licensed technology developed and studied by the lab of Dr Evan Newell at Singapore Immunology Network in A*STAR.
immunoSCAPE employs cutting-edge technologies and mass cytometry to measure alterations of immune cells, and in particular T cell specificity, for biomarker and target identification, offering valuable insights on efficacy & safety of immunotherapies in R&D and clinical phase.
UTEC value up
UTEC is instrumental in academic collaborations, business development and team-building strategy.
Immunological insights provided by immunoSCAPE
Map of immune response landscap